Myocardial hypertrophy and its role in heart failure with preserved ejection fraction.
Heinzel FR, Hohendanner F, Jin G, Sedej S, Edelmann F.
J Appl Physiol (1985). 2015 Nov 15;119(10):1233-42. doi: 10.1152/japplphysiol.00374.2015. Epub 2015 Jul 16.
Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure.
Oka T, Akazawa H, Naito AT, Komuro I.
Circ Res. 2014 Jan 31;114(3):565-71. doi: 10.1161/CIRCRESAHA.114.300507.
Cardiac Hypertrophy: An Introduction to Molecular and Cellular Basis.
Samak M, Fatullayev J, Sabashnikov A, Zeriouh M, Schmack B, Farag M, Popov AF, Dohmen PM, Choi YH, Wahlers T, Weymann A.
Med Sci Monit Basic Res. 2016 Jul 23;22:75-9. doi: 10.12659/MSMBR.900437.
ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy.
Gallo S, Vitacolonna A, Bonzano A, Comoglio P, Crepaldi T.
Int J Mol Sci. 2019 May 1;20(9):2164. doi: 10.3390/ijms20092164.
Myocardial energetics in cardiac hypertrophy.
Zhang J.
Clin Exp Pharmacol Physiol. 2002 Apr;29(4):351-9. doi: 10.1046/j.1440-1681.2002.03657.x.
CaMKII in myocardial hypertrophy and heart failure.
Anderson ME, Brown JH, Bers DM.
J Mol Cell Cardiol. 2011 Oct;51(4):468-73. doi: 10.1016/j.yjmcc.2011.01.012. Epub 2011 Jan 27.
Exercise-induced myocardial hypertrophy preconditioning promotes fibroblast senescence and improves myocardial fibrosis through Nrf2 signaling pathway.
Wei X, Mao Y, Chen Z, Kang L, Xu B, Wang K.
Cell Cycle. 2023 Jul;22(13):1529-1543. doi: 10.1080/15384101.2023.2215081. Epub 2023 Jun 13.
Structural bases of myocardial hypertrophy.
Meessen H.
Br Heart J. 1971;33(Suppl):Suppl:94-9. doi: 10.1136/hrt.33.suppl.94.
Myocardial reverse remodeling.
Hellawell JL, Margulies KB.
Cardiovasc Ther. 2012 Jun;30(3):172-81. doi: 10.1111/j.1755-5922.2010.00247.x. Epub 2010 Nov 25.
Myocardial perfusion dependent and independent mechanisms of regional myocardial dysfunction in hypertrophy.
Vatner SF, Hittinger L.
Basic Res Cardiol. 1993;88 Suppl 1:81-95. doi: 10.1007/978-3-642-72497-8_6.
